VAERS Reports 06721A

VAERS 2258300

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 06721A

mild

Staat: AZ
Alter: 29,0
Geschlecht: F
Eingang: 29.04.2022
Impfdatum: 03.12.2021
Beginn: 03.12.2021
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Arthralgia Blood test normal Electromyogram Feeling abnormal Fibromyalgia Inflammation Insomnia Lethargy Magnetic resonance imaging normal Memory impairment Pain X-ray normal

Symptomtext

I got diagnosed with fibromyalgia on Friday April 15, 2022. Symptoms are overall widespread pain, join pain and inflammation, brain fog, short term memory is affected, sometimes in different parts of my body feels dullness as if just vaccinated, anxiety, lethargy, and trouble sleeping. I was sent to physical therapy for 4 months.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: EMG results pending, blood work all came back clean, x-rays/ MRI = came back negative.
Aktuelle Erkrankungen: No
Vorgeschichte: I have complex regional pain syndrome type 1 in my right foot only; neurological condition
Andere Medikamente: Daily vitamin; topical tretinoin .1% for acne
Allergien: Shellfish; Pineapple
Vorherige Impfungen: I fainted after flu vaccine and it's happened a couple of times, first time was 2013 and then 2015.

VAERS 1942194

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 06721A

mild

Staat: FL
Alter: 40,0
Geschlecht: F
Eingang: 11.12.2021
Impfdatum: 10.12.2021
Beginn: 10.12.2021
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Pain Pain in extremity

Symptomtext

Headache, body aches, sore arm, fatigue beginning about 9 hours after vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: asthma, HSV-2, vulvodynia
Andere Medikamente: Albuterol, Breo ellipta, Milli OCP, Singular, Claritin
Allergien: pollen and PCN
Vorherige Impfungen: -

VAERS 1922673

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 06721A

mild

Staat: FL
Alter: 48,0
Geschlecht: M
Eingang: 04.12.2021
Impfdatum: 23.11.2021
Beginn: 01.11.2021
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Hyperhidrosis Inappropriate schedule of product administration Influenza like illness Lymphadenopathy Pyrexia Vaccination complication

Symptomtext

I had a reaction; Lymph nodes underneath my arm began to swell/Underneath my arm it's like a water bed; Fever; Inappropraite schedule of vaccine; Sweats; The whole nine yards and felt like he had the flu; Cough; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I had a reaction), HYPERHIDROSIS (Sweats), COUGH (Cough), INFLUENZA LIKE ILLNESS (The whole nine yards and felt like he had the flu) and LYMPHADENOPATHY (Lymph nodes underneath my arm began to swell/Underneath my arm it's like a water bed) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 06721A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Previously administered products included for COVID-19 vaccination: pfizer (The first dose was given ,into his left arm (he thinks) . The lot number was ER3729) on 12-Apr-2021, pfizer (The second dose was given and Also into his left arm (he thinks) Lot number EV0175.Each of these doses were given) on 03-May-2021. Past adverse reactions to the above products included No adverse event with pfizer and pfizer. On 23-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In November 2021, the patient experienced COUGH (Cough). On 23-Nov-2021, the patient experienced HYPERHIDROSIS (Sweats), INFLUENZA LIKE ILLNESS (The whole nine yards and felt like he had the flu), PYREXIA (Fever) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropraite schedule of vaccine). On 26-Nov-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes underneath my arm began to swell/Underneath my arm it's like a water bed). On an unknown date, the patient experienced VACCINATION COMPLICATION (I had a reaction). In November 2021, COUGH (Cough) and LYMPHADENOPATHY (Lymph nodes underneath my arm began to swell/Underneath my arm it's like a water bed) had resolved. On 23-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropraite schedule of vaccine) had resolved. On 24-Nov-2021, HYPERHIDROSIS (Sweats), INFLUENZA LIKE ILLNESS (The whole nine yards and felt like he had the flu) and PYREXIA (Fever) had resolved. At the time of the report, VACCINATION COMPLICATION (I had a reaction) outcome was unknown. Patient received the Moderna booster shot on 23NOV2021 into the muscle of his right, upper arm at the,Lot number was difficult to discern, but thinks it was 06721A. No expiration date was provided. Patient received the Pfizer vaccines as the primary series.Also into his left arm (Patient thinks). No concomitant medication were reported. No Treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 29-Nov-2021: Significant Follow-up appended-Includes event updates, historical vaccine updates.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1755992

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 06721A

mild

Staat: PA
Alter: 29,0
Geschlecht: M
Eingang: 02.10.2021
Impfdatum: 23.09.2021
Beginn: 24.09.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Vaccination site pain

Symptomtext

This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (muscle pain in the vaccination site, but doesn't have problems with it, just wanted to report it) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 06721A) for COVID-19 immunization. No medical history reported. On Sep 23, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Sep 24, 2021, patient experienced vaccination site pain (muscle pain in the vaccination site, but doesn't have problems with it, just wanted to report it). At the time of the report, vaccination site pain (muscle pain in the vaccination site, but doesn't have problems with it, just wanted to report it) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information reported. On Sept 24, 2021, the pain started. The patient reported the second dose was scheduled for Oct 20, 2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2521402

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 06721A

gering

Staat: MI
Alter: 53,0
Geschlecht: M
Eingang: 02.12.2022
Impfdatum: 19.11.2021
Beginn: 28.11.2022
Tage bis Beginn: 374,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Inappropriate schedule of product administration No adverse event

Symptomtext

No Adverse event; Patient received expired vaccine; 1st dose received on 19-Nov-2021/2nd dose received on 28-Nov-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose received on 19-Nov-2021/2nd dose received on 28-Nov-2022) and NO ADVERSE EVENT (No Adverse event) in a 53-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 054B22A and 06721A) for COVID-19 prophylaxis. No Medical History information was reported. On 19-Nov-2021, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 28-Nov-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 28-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose received on 19-Nov-2021/2nd dose received on 28-Nov-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose received on 19-Nov-2021/2nd dose received on 28-Nov-2022) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose received on 19-Nov-2021/2nd dose received on 28-Nov-2022). No concomitant medications were reported. The patient had not reported any adverse reactions to this dose at this time. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -